Pharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, WI 53705, USA.
Sea Samples, 369 Westshore Drive, Summerland Key, FL 33042, USA.
Mar Drugs. 2019 Dec 12;17(12):698. doi: 10.3390/md17120698.
To date, studies describing myxobacterial secondary metabolites have been relatively scarce in comparison to those addressing actinobacterial secondary metabolites. This realization suggests the immense potential of myxobacteria as an intriguing source of secondary metabolites with unusual structural features and a wide array of biological activities. Marine-derived myxobacteria are especially attractive due to their unique biosynthetic gene clusters, although they are more difficult to handle than terrestrial myxobacteria. Here, we report the discovery of two new pyrazinone-type molecules, enhypyrazinones A and B, from a marine-derived myxobacterium sp. Their structures were elucidated by HRESIMS and comprehensive NMR data analyses. Compounds and , which contain a rare trisubstituted-pyrazinone core, represent a unique class of molecules from sp.
迄今为止,与研究放线菌次生代谢产物的研究相比,描述粘细菌次生代谢产物的研究相对较少。这一认识表明,粘细菌具有作为具有独特结构特征和广泛生物活性的次生代谢产物的有趣来源的巨大潜力。海洋来源的粘细菌由于其独特的生物合成基因簇而特别吸引人,尽管它们比陆地粘细菌更难处理。在这里,我们报道了从海洋来源的粘细菌 sp. 中发现了两种新的吡嗪酮型分子 enhypyrazinones A 和 B。它们的结构通过 HRESIMS 和全面的 NMR 数据分析阐明。化合物 和 ,含有罕见的三取代吡嗪酮核心,代表了 sp. 的一类独特的分子。